NFE2L2 and cancer: This particular NRF2-driven pro-proliferation metabolic program was shown to be dependent on the hyperactivation of the PI3K-AKT pathway, a pathway that is typically deregulated in cancer [127, 128] providing further support to the premise that cancer cells and their oncogenic pathways utilize NRF2 to their own advantage.